Psychedelic Stocks UK Regulators Approve Clinical Trial Testing DMT as a Potential Depression Treatment By Larry Zweig December 22, 2020 UK watchdogs recently gave the green light to researchers exploring the potential medical properties of psychedelics. The approval will allow researchers to study dimethyltryptamine (DMT) as a potential treatment for depression. ...
Psychedelic Stocks UK Regulators Explore DMT As A Potential Anti-Depression Therapy By Larry Zweig December 19, 2020 UK researchers are planning to conduct a clinical study that will give them insights into dimethyltryptamine’s (DMT) mechanisms that provide therapeutic advantages against mental health illnesses. The research will be backed by...